Aspergillosis
📧 Sign up to get email alerts when something new happens for Aspergillosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: Safety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant Recipients [Phase 2]
Phase 2 safety and efficacy trial of inhaled AmBisome (liposomal amphotericin B) to prevent Aspergillus colonization in lung transplant reci…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis [Phase 3]
A Phase 3 study is evaluating SPK-843 for pulmonary fungal infections including cryptococcosis and aspergillosis. The trial investigates eff…
-
CLINICAL_TRIALS trial_result · 2011-05-20Clinical Trial Update: Surveillance of Fungal Infections During Construction Activity
This completed clinical trial update reports on surveillance of fungal infections, specifically aspergillosis, during construction activity.
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of voriconazole for fungal infections has completed. The study included candidia…
-
CLINICAL_TRIALS research · 2011-03-16Clinical Trial Update: Pre-hospital Risk Factors for Invasive Fungal Infection
This clinical trial update discusses pre-hospital risk factors for invasive fungal infections in patients with acute myeloid leukemia and re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Multicenter, Prospective, Randomized, Double-Blind Clinical Trial Comparing Itraconazole Oral Solution in Cyclodextrin to Placebo in the Treatment of Aspergilloma [Phase 2]
A multicenter, randomized, double-blind Phase 2 trial evaluated itraconazole oral solution (cyclodextrin formulation) versus placebo for asp…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis
A clinical trial update examining how IL-17–producing regulatory T cells may promote immune tolerance in liver transplant recipients who hav…
-
FDA approval · 2010-03-05FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects [Phase 4]
A Phase 4 clinical trial update reporting results of a study comparing concentrations of anidulafungin and voriconazole in the lungs after i…
-
CLINICAL_TRIALS trial_result · 2010-01-07Clinical Trial Update: Voriconazole For Chronic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]
Pfizer-sponsored Phase 2/3 trials evaluated voriconazole for chronic bronchopulmonary aspergillosis. The results were posted in January 2010…
-
EMA withdrawal · 2009-08-04EMA Lapsed: Posaconazole SP (posaconazole) — Schering-Plough Europe
EMA status shows Posaconazole SP has lapsed; therapeutic areas include candidiasis, mycoses, coccidioidomycosis, and aspergillosis.
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection
This completed clinical trial assesses caspofungin acetate (Cancidas) for treating candidiasis and aspergillosis.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients [Phase 3]
A Phase 3 trial comparing fluconazole with FK463 to prevent fungal infections in bone marrow transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections [Phase 3]
Open-label Phase III multicenter trial evaluating voriconazole for invasive fungal infections has completed. The study assessed efficacy, sa…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Voriconazole to Prevent Systemic Fungal Infections in Children [Phase 1]
This Phase 1 trial evaluates voriconazole for the prevention of systemic fungal infections in pediatric patients.
-
CLINICAL_TRIALS research · 2007-04-13Clinical Trial Update: Evaluate Three Methods for Diagnosis of Invasive Fungal Infection in Chinese Patients After HSCT
A clinical trial sponsored by Peking University is evaluating three diagnostic methods for invasive fungal infection in Chinese patients aft…
-
FDA approval · 2006-09-15FDA Approved: NOXAFIL — Original Application (Merck Sharp & Dohme LLC)
NOXAFIL (posaconazole) received FDA approval through its original application as a broad-spectrum antifungal agent for the prevention of inv…